Cargando…
Beyond direct killing—novel cellular immunotherapeutic strategies to reshape the tumor microenvironment
The clinical use of cellular immunotherapies is gaining momentum and the number of approved indications is steadily increasing. One class of cellular therapies—chimeric antigen receptor (CAR)-modified T cells—has achieved impressive results in distinct blood cancer indications. These existing cellul...
Autores principales: | Huynh, Duc, Winter, Pia, Märkl, Florian, Endres, Stefan, Kobold, Sebastian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10121530/ https://www.ncbi.nlm.nih.gov/pubmed/36167831 http://dx.doi.org/10.1007/s00281-022-00962-4 |
Ejemplares similares
-
Syringeable immunotherapeutic nanogel reshapes tumor microenvironment and prevents tumor metastasis and recurrence
por: Song, Chanyoung, et al.
Publicado: (2019) -
Nanomedicines targeting activation of STING to reshape tumor immune microenvironment and enhance immunotherapeutic efficacy
por: Chen, Shanshan, et al.
Publicado: (2023) -
Beyond checkpoint inhibition – Immunotherapeutical strategies in combination with radiation
por: Eckert, F., et al.
Publicado: (2017) -
Killing Mechanisms of Chimeric Antigen Receptor (CAR) T Cells
por: Benmebarek, Mohamed-Reda, et al.
Publicado: (2019) -
Immunotherapy: Reshape the Tumor Immune Microenvironment
por: LV, Bingzhe, et al.
Publicado: (2022)